Preklinický vývoj inhibitorů CDK11 - identifikace látek vhodných pro patentovou ochranu a komercializaci

• Title in English: Preclinical development of CDK11 inhibitors - identification of compounds suitable for patent protection and commercialization
• Authors: BLAŽEK Dalibor; PARUCH Kamil
• Year of publication: 2024
• Type: Outcomes put into operation (prototype, working sample)
• MU Faculty or unit: Central European Institute of Technology
• Description: The project will identify and characterise chemical compounds that inhibit CDK11 and might be potentially suitable for patent protection and commercialization.

Related projects

• DIANA panel for testing of selectivity of inhibitors of clinically relevant protein kinases and its application in the drug discovery market. Preclinical development of new inhibitors of CDK11 - key enzyme for growth of cancer cells.